0000-0003-2516-5146 About
Supradip Dutta
PhD | Virologist | Immunologist | Molecular Epidemiologist|Vaccine design|Bioinformatics
I am a Ph.D. qualified virologist from ICMR-NICED (ICMR-NIRBI), affiliated with Jadavpur University. I have over 8 years of experience in viral genomics, immunology, and vaccine design, particularly focusing on dengue and hepatitis C virus (HCV). My work bridges molecular virology, immunoinformatics, and public health, contributing to national disease surveillance, drug resistance mapping, and epitope-based vaccine research.
🧪 Core Skills & Expertise:
Molecular Biology: PCR, qPCR, Sanger sequencing, ELISA, RNA/DNA handling
Immunology: T-cell epitope prediction, immune profiling, vaccine target identification
Microbiology & Virology: Virus propagation, diagnostic virology, biosafety techniques
Cell Culture & Flow Cytometry: Mammalian systems, FACS analysis
Computational Biology: Molecular docking, immunoinformatics, R programming
Vaccine & Drug Design: In silico vaccine modelling, antiviral screening
Molecular Epidemiology: Viral mutation tracking, serotyping, outbreak analytics
Employment
-
National Institute of Cholera and Enteric Diseases RESEARCH SCHOLAR2017 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (12)
- Differential Proteomic Profiling of Responders and Non-responders to Direct-Acting Antivirals Treatment in Chronic Hepatitis C Virus Infection Save
- Prediction of potential NS3-based T cell epitopes of hepatitis C virus by in-silico and in-vitro approach Save
- Assessment of direct-acting antiviral treatment outcomes in patients with chronic hepatitis C infected with various HCV genotypes: Insights from a real-world cohort in West Bengal, India Save
- Emergence of HCV genotype 6 and its new variants among intravenous drug users in Manipur, a north-eastern state of India Save
- Impact of hepatitis C virus genotype on the efficacy of the direct-acting antivirals in chronic kidney disease patients in West Bengal, India Save
- Efficacy of Different Combinations of Direct-Acting Antivirals Against Different Hepatitis C Virus-Infected Population Groups: An Experience in Tertiary Care Hospitals in West Bengal, India Save
- The Efficacy and Safety of Sofosbuvir and Daclatasvir Treatment in Children and Adolescents With Thalassemia and Hepatitis C Virus Infection Save
- Geographic information system-aided evaluation of epidemiological trends of dengue serotypes in West Bengal, India Save
- Changing pattern of circulating dengue serotypes in the endemic region: An alarming risk to the healthcare system during the pandemic Save
- Molecular Epidemiology of HCV Infection among Multi-Transfused β-Thalassemia Patients in Eastern India: A Six-Year Observation Save